Polysulfide inhibits hypoxia-elicited hypoxia-inducible factor activation in a mitochondria-dependent manner.


Journal

Mitochondrion
ISSN: 1872-8278
Titre abrégé: Mitochondrion
Pays: Netherlands
ID NLM: 100968751

Informations de publication

Date de publication:
07 2021
Historique:
received: 08 02 2021
revised: 20 05 2021
accepted: 11 06 2021
pubmed: 17 6 2021
medline: 27 1 2022
entrez: 16 6 2021
Statut: ppublish

Résumé

In cellular signaling, the diverse physiological actions of biological gases, including O

Identifiants

pubmed: 34133955
pii: S1567-7249(21)00080-5
doi: 10.1016/j.mito.2021.06.007
pii:
doi:

Substances chimiques

HIF1A protein, human 0
Hypoxia-Inducible Factor 1, alpha Subunit 0
Sulfides 0
polysulfide 9080-49-3
Von Hippel-Lindau Tumor Suppressor Protein EC 2.3.2.27
VHL protein, human EC 6.3.2.-
Oxygen S88TT14065

Banques de données

figshare
['10.6084/m9.figshare.13558220']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-266

Informations de copyright

Copyright © 2021 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Auteurs

Takeo Uba (T)

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Japan; Department of Anesthesiology, Kansai Medical University, Hirakata 573-1010, Japan.

Yoshiyuki Matsuo (Y)

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Japan.

Chisato Sumi (C)

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Japan.

Tomohiro Shoji (T)

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Japan; Department of Anesthesiology, Kansai Medical University, Hirakata 573-1010, Japan.

Kenichiro Nishi (K)

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Japan.

Munenori Kusunoki (M)

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Japan.

Hiroshi Harada (H)

Laboratory of Cancer Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan.

Hideo Kimura (H)

Department of Pharmacology, Faculty of Pharmaceutical Science, Sanyo-Onoda City University, Sanyo-Onoda 756-0884, Japan.

Hidemasa Bono (H)

Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima 739-0046, Japan.

Kiichi Hirota (K)

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Japan. Electronic address: khirota-kyt@umin.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH